VTX2735

· Zomagen Biosciences Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for VTX2735, covering 2025-03-10 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis [Phase 2]